ArticleJAMA network open2025

Trends in Formulary Coverage of Nonprotected Class Drugs Granted FDA Accelerated Approval.

Shelley A Jazowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.